IE50892B1 - Process for preparing insulin esters - Google Patents

Process for preparing insulin esters

Info

Publication number
IE50892B1
IE50892B1 IE251/81A IE25181A IE50892B1 IE 50892 B1 IE50892 B1 IE 50892B1 IE 251/81 A IE251/81 A IE 251/81A IE 25181 A IE25181 A IE 25181A IE 50892 B1 IE50892 B1 IE 50892B1
Authority
IE
Ireland
Prior art keywords
gly
process according
insulin
ala
leu
Prior art date
Application number
IE251/81A
Other languages
English (en)
Other versions
IE810251L (en
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK57480A external-priority patent/DK147109C/da
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of IE810251L publication Critical patent/IE810251L/xx
Publication of IE50892B1 publication Critical patent/IE50892B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IE251/81A 1980-02-11 1981-02-10 Process for preparing insulin esters IE50892B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK57480A DK147109C (da) 1980-02-11 1980-02-11 Fremgangsmaade til fremstilling af humant insulin eller humane insulinestere eller et salt eller kompleks deraf
DK366280 1980-08-28

Publications (2)

Publication Number Publication Date
IE810251L IE810251L (en) 1981-08-11
IE50892B1 true IE50892B1 (en) 1986-08-06

Family

ID=26064239

Family Applications (1)

Application Number Title Priority Date Filing Date
IE251/81A IE50892B1 (en) 1980-02-11 1981-02-10 Process for preparing insulin esters

Country Status (4)

Country Link
US (1) US4343898A (enExample)
AT (1) AT399881B (enExample)
FR (1) FR2475542B1 (enExample)
IE (1) IE50892B1 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK319780A (da) * 1980-07-24 1982-01-25 Forenede Bryggerier As Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyren i insuliner
DK353781A (da) * 1981-08-10 1983-02-11 Novo Industri As Fremgangsmaade til fremstilling af insulinderivater
AU551174B2 (en) * 1981-09-15 1986-04-17 Nordisk Insulinlaboratorium Enzymatic preparation of human insulin or b-30 esters thereof
NL8201650A (nl) * 1982-04-21 1983-11-16 Akzo Nv Semisynthetische bereiding van humane insuline.
US4528134A (en) * 1982-12-27 1985-07-09 University Of Tn Research Corporation Method of separating A14 -125 I-insulin from heterogeneously labeled insulin molecules for biological studies
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DK257988D0 (da) * 1988-05-11 1988-05-11 Novo Industri As Nye peptider
DE3844211A1 (de) * 1988-12-29 1990-07-05 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
DK134189D0 (da) * 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser
US5512459A (en) * 1993-07-20 1996-04-30 Bionebraska, Inc. Enzymatic method for modification or recombinant polypeptides
HUP0004169A3 (en) 1997-10-24 2001-06-28 Lilly Co Eli Insoluble insulin compositions and process for production thereof
CO4970787A1 (es) * 1997-12-23 2000-11-07 Lilly Co Eli Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea
JP4795599B2 (ja) 1999-12-29 2011-10-19 ノボ ノルディスク アクティーゼルスカブ 酵母において改良された発酵収率を有するインスリン前駆体及びインスリン前駆体類似体の製造方法
AR025646A1 (es) * 2000-09-13 2002-12-04 Beta Lab Sa Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
CA2464616C (en) * 2001-11-19 2012-07-24 Are Bogsnes Process for preparing insulin compounds
US7396903B2 (en) * 2001-11-19 2008-07-08 Novo Nordisk A/S Process for preparing insulin compounds
UA46667C2 (en) * 2001-12-29 2006-01-16 Omakooe Ltd Liability Company Method for preparing semisynthetic human insulin
EP2106790B1 (en) * 2004-03-12 2012-10-24 Biodel, Inc. Rapid acting drug delivery compositions
US20080090753A1 (en) 2004-03-12 2008-04-17 Biodel, Inc. Rapid Acting Injectable Insulin Compositions
US20080085298A1 (en) * 2004-03-12 2008-04-10 Biodel, Inc. Rapid Mucosal Gel or Film Insulin Compositions
US20080248999A1 (en) * 2007-04-04 2008-10-09 Biodel Inc. Amylin formulations
US20080096800A1 (en) * 2004-03-12 2008-04-24 Biodel, Inc. Rapid mucosal gel or film insulin compositions
SI1881850T1 (sl) 2005-05-13 2011-01-31 Lilly Co Eli Glp-1 pegilirane spojine
ES2361166T3 (es) * 2005-07-08 2011-06-14 Biocon Limited Conjugados de insulina.
US8084420B2 (en) * 2005-09-29 2011-12-27 Biodel Inc. Rapid acting and long acting insulin combination formulations
US7713929B2 (en) * 2006-04-12 2010-05-11 Biodel Inc. Rapid acting and long acting insulin combination formulations
WO2007121256A2 (en) * 2006-04-12 2007-10-25 Biodel, Inc. Rapid acting and long acting insulin combination formulations
EP2007804B1 (en) 2006-04-20 2014-06-18 Amgen, Inc Glp-1 compounds
WO2009089181A1 (en) * 2008-01-04 2009-07-16 Blodel, Inc. Insulin formulations for insulin release as a function of tissue glucose levels
WO2010013762A1 (ja) 2008-07-30 2010-02-04 武田薬品工業株式会社 メタスチン誘導体およびその用途
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
US8618049B2 (en) 2009-09-08 2013-12-31 Stephen B. H. Kent Ester insulin
EP2585483A1 (en) 2010-06-23 2013-05-01 Novo Nordisk A/S Human insulin containing additional disulfide bonds
CA2802510A1 (en) 2010-06-23 2011-12-29 Novo Nordisk A/S Insulin derivatives containing additional disulfide bonds
EP2585484A1 (en) 2010-06-23 2013-05-01 Novo Nordisk A/S Insulin analogues containing additional disulfide bonds
CN103533952B (zh) 2011-03-15 2017-02-15 诺沃—诺迪斯克有限公司 包含半胱氨酸置换的人胰岛素类似物和衍生物
EP2720711A1 (en) 2011-06-15 2014-04-23 Novo Nordisk A/S Multi substituted insulins
EP2925345B1 (en) 2012-12-03 2018-09-05 Merck Sharp & Dohme Corp. Method for making o-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues
US20160115216A1 (en) 2013-06-07 2016-04-28 Novo Nordisk A/S Method for Making Mature Insulin Polypeptides
MY177247A (en) * 2013-12-23 2020-09-10 Biocon Biologics Ltd Method of production of human insulin methyl ester
CA3071686A1 (en) 2017-08-17 2019-02-21 Novo Nordisk A/S Novel acylated insulin analogues and uses thereof
WO2023144240A1 (en) 2022-01-26 2023-08-03 Novo Nordisk Research Centre Oxford Limited Glucose sensitive insulin derivatives and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3276961A (en) * 1963-04-08 1966-10-04 Squibb & Sons Inc Process for preparing human insulin

Also Published As

Publication number Publication date
AT399881B (de) 1995-08-25
ATA63681A (de) 1994-12-15
IE810251L (en) 1981-08-11
US4343898A (en) 1982-08-10
FR2475542A1 (enExample) 1981-08-14
FR2475542B1 (enExample) 1988-09-09

Similar Documents

Publication Publication Date Title
US4343898A (en) Process for preparing esters of human insulin
CA1162868A (en) Process for preparing insulin esters
Kemmler et al. Studies on the conversion of proinsulin to insulin: I. Conversion in vitro with trypsin and carboxypeptidase B
KR100574580B1 (ko) 정확하게 결합된 시스틴 브릿지를 갖는 인슐린 또는 인슐린유도체를 수득하는 방법
Rochat et al. The amino‐acid sequence of neurotoxin II of Androctonus australis Hector
FI66751B (fi) Foerfarande foer framstaellning av ett stabilt insulinpreparatmed laongtidsverkan
KR880001107B1 (ko) 인체 인슐린 및 그의 유도체의 제조방법
Harboe et al. The Activation of Bovine Pepsinogen: SEQUENCE OF THE PEPTIDES RELEASED, IDENTIFICATION OF A PEPSIN INHIBITOR
IE57709B1 (en) Novel insulin derivatives,processes for their preparation and their use,and pharmaceutical agents for the treatment of diabetes mellitus
US4430266A (en) Process for producing an insulin precursor
Fraenkel-Conrat et al. A general micromethod for the stepwise degradation of peptides
FI79853C (fi) Foerfarande foer framstaellning av insulinderivat.
US4489159A (en) Process for preparing esters of human insulin
EP0017938A1 (en) Process for preparing a B30-threonine insulin
Seehra et al. Bacteriorhodopsin precursor. Characterization and its integration into the purple membrane.
EP0037255B1 (en) Process for producing an insulin precursor
CA1195273A (en) Process for converting preproinsulin analogs into insulin
Lindsay et al. Monosubstituted 2, 2‐Dimethyl‐3‐Formyl‐L‐Thiazolidine‐4‐Carbonyl‐Insulins
Markussen et al. Duck insulin: isolation, crystallization and amino acid sequence
KOTAKI Studies on insulin II. Amino acid composition and terminal sequences of bonito insulin
Ooi et al. Structural studies of ribonuclease. XII. Enzymic hydrolysis of active tryptic modifications of ribonuclease
US3752798A (en) Tris-na1,nb1,nepsilonb29 - (3-x-3-oxo - 1-y-prop-1-en-1-yl)(ndelta-(4-z-6-r-pyrimidin - 2 - yl) ornithine b22)-insulins and their preparation
Wälti et al. Synthesis of [1-(L-2-hydroxy-3-mercaptopropanoic acid)] oxytocin, a highly potent analogue of oxytocin
KOTAKI Studies on Insulin

Legal Events

Date Code Title Description
MM4A Patent lapsed